Matches in Wikidata for { <http://www.wikidata.org/entity/Q63812605> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q63812605 description "clinical trial" @default.
- Q63812605 description "ensayu clínicu" @default.
- Q63812605 description "klinisch onderzoek" @default.
- Q63812605 description "клінічне випробування" @default.
- Q63812605 name "Early Prophylaxis Immunologic Challenge (EPIC) Study" @default.
- Q63812605 type Item @default.
- Q63812605 label "Early Prophylaxis Immunologic Challenge (EPIC) Study" @default.
- Q63812605 prefLabel "Early Prophylaxis Immunologic Challenge (EPIC) Study" @default.
- Q63812605 P1050 Q63812605-1BF6B5C5-BD87-482A-916E-21384605CB47 @default.
- Q63812605 P1132 Q63812605-DD777923-F70A-4E53-A675-A13855CE73D3 @default.
- Q63812605 P1476 Q63812605-49802155-32DA-4CFF-AE19-F9B025E6C585 @default.
- Q63812605 P17 Q63812605-0DF390AA-90A2-4AEC-91BA-D191FCEFDDD0 @default.
- Q63812605 P17 Q63812605-104BDB17-21BF-46E9-A5A9-FBCCDDB6DEE6 @default.
- Q63812605 P17 Q63812605-32D29370-DC2A-4C26-B877-DF08C965ADFC @default.
- Q63812605 P17 Q63812605-84772471-3636-430E-A87F-AEA3C1AEE8AC @default.
- Q63812605 P17 Q63812605-964858E1-66CE-4F5C-9109-A5B394F1AD4C @default.
- Q63812605 P17 Q63812605-A7F2B64D-E6EB-470D-BE12-07C8281641DD @default.
- Q63812605 P17 Q63812605-C7534A18-645C-47D3-AA22-D2C576382512 @default.
- Q63812605 P17 Q63812605-D17B2253-859E-49C3-96C8-3ABD33A88A76 @default.
- Q63812605 P17 Q63812605-D797B88F-E88B-408D-BA3B-6A0BC953036B @default.
- Q63812605 P1813 Q63812605-98C11630-88E7-443D-8B76-E7C782A2A5BE @default.
- Q63812605 P3098 Q63812605-08DF399F-576F-4C9D-9388-B078C77A74B8 @default.
- Q63812605 P31 Q63812605-EA156842-E376-4522-A612-9C3234B83DF6 @default.
- Q63812605 P580 Q63812605-77149807-BE6F-4381-A150-8C17A9FD266E @default.
- Q63812605 P582 Q63812605-A02A292C-E35A-46AA-B33C-A26B09DB8C6F @default.
- Q63812605 P6099 Q63812605-58FAEA7A-5746-42E7-81FE-33D904441F9D @default.
- Q63812605 P8363 Q63812605-9B483B9F-B72A-452B-B557-DCB5D0A61CB0 @default.
- Q63812605 P1050 Q2092064 @default.
- Q63812605 P1132 "+22" @default.
- Q63812605 P1476 "A Phase 3b Clinical Study to Assess Whether Regular Administration of ADVATE in the Absence of Immunological Danger Signals Reduces the Incidence Rate of Inhibitors in Previously Untreated Patients With Hemophilia A" @default.
- Q63812605 P17 Q16 @default.
- Q63812605 P17 Q183 @default.
- Q63812605 P17 Q219 @default.
- Q63812605 P17 Q29 @default.
- Q63812605 P17 Q36 @default.
- Q63812605 P17 Q37 @default.
- Q63812605 P17 Q40 @default.
- Q63812605 P17 Q403 @default.
- Q63812605 P17 Q55 @default.
- Q63812605 P1813 "EPIC" @default.
- Q63812605 P3098 "NCT01376700" @default.
- Q63812605 P31 Q30612 @default.
- Q63812605 P580 "2011-08-26T00:00:00Z" @default.
- Q63812605 P582 "2012-11-16T00:00:00Z" @default.
- Q63812605 P6099 Q42824827 @default.
- Q63812605 P8363 Q78089383 @default.